UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity

Leukemia, 2018-02, Vol.32 (2), p.520-531

2018

Volltextzugriff (PDF)

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma leukemia effects and safety

Leukemia, 2010-06, Vol.24 (6), p.1160-1170

2010

Volltextzugriff (PDF)

Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant

Leukemia, 2013-07, Vol.27 (7), p.1538-1547

2013

Volltextzugriff (PDF)

Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects

Journal of Immunology Research, 2016-01, Vol.2016, p.7853028-2

2016

Volltextzugriff (PDF)

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals

Gene therapy, 2013-09, Vol.20 (9), p.958-962

2013

Volltextzugriff (PDF)

CD30‐CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR THERAPY OF HODGKIN LYMPHOMA (HL)

Hematological oncology, 2019-06, Vol.37 (S2), p.168-168

2019

Volltextzugriff (PDF)

Direct comparison of in vivo fate of second and third-generation CD19-specific chimeric antigen receptor (CAR)-T cells in patients with b cell non-hodgkin lymphoma (B-NHL): Reversal of toxicity from tonic signaling

Cytotherapy (Oxford, England), 2017-05, Vol.19 (5), p.S9-S9

2017

Volltextzugriff (PDF)

Late donor cardiectomy after paediatric heterotopic cardiac transplantation

The Lancet (British edition), 2009-08, Vol.374 (9687), p.387-392

2009

Volltextzugriff (PDF)

Chimeric Antigen Receptor Gene-Modified Virus-Specific T-Cell Expanded in Patients with Reactivated Epstein-Barr Virus Post Allogeneic Stem Cell Transplant

Cytotherapy (Oxford, England), 2016-06, Vol.18 (6), p.S9-S10

2016

Volltextzugriff (PDF)

Generation and administration of autologous T cells transduced with a 3rd generation GD2 chimeric antigen receptor for patients with relapsed or refractory neuroblastoma

Cytotherapy (Oxford, England), 2014-04, Vol.16 (4), p.S19-S20

2014

Volltextzugriff (PDF)

Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L IL-2 tumor vaccine

Leukemia, 2010-03, Vol.24 (3), p.563-572

2010

Volltextzugriff (PDF)

Generation of EBV-Specific CD4+ Cytotoxic T Cells from Virus Naive Individuals

The Journal of immunology (1950), 2002-01, Vol.168 (2), p.909-918

2002

Volltextzugriff (PDF)

Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?"

Human gene therapy, 2009-11, Vol.20 (11), p.1229-1239

2009

Volltextzugriff (PDF)

Ultra low-dose IL-2 mediated expansion of regulatory T cells as GvHD prophylaxis for recipients of allogeneic hematopoietic stem cells

Cytotherapy (Oxford, England), 2013-04, Vol.15 (4), p.S41-S42

2013

Volltextzugriff (PDF)

Naïve T-cell-derived CTL recognize atypical epitopes of CMVpp65 with higher avidity than CMV-seropositive donor-derived CTL - a basis for treatment of post-transplant viral infection by adoptive transfer of T-Cells from virus-naïve donors

Cytotherapy (Oxford, England), 2013-04, Vol.15 (4), p.S9-S9

2013

Volltextzugriff (PDF)

Improving immune reconstitution after cord blood transplantation using ex vivo expanded virus-specific T cells: a phase I clinical study

Cytotherapy (Oxford, England), 2013-04, Vol.15 (4), p.S21-S21

2013

Volltextzugriff (PDF)

Infusion of CD19-directed/multivirus specific-cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation for B cell malignancies

Cytotherapy (Oxford, England), 2013-04, Vol.15 (4), p.S7-S7

2013

Volltextzugriff (PDF)

Immunotherapy: B7H3-CAR NK CELLS AND DNR CO-TRANSDUCED NK SHOWS MAINTAIN THEIR POTENCY AGAINST TGF-B MEDIATED IMMUNE SUPPRESSION

Cytotherapy (Oxford, England), 2022-05, Vol.24 (5), p.S38

2022

Volltextzugriff (PDF)

Genetic modification of human T lymphocytes for the treatment of hematologic malignancies

Haematologica (Roma), 2012-11, Vol.97 (11), p.1622-1631

2012

Volltextzugriff (PDF)

Human antibody titers to Epstein–Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay

Virology (New York, N.Y.), 2009-09, Vol.391 (2), p.249-256

2009

Volltextzugriff (PDF)

Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease

Haematologica (Roma), 2013-04, Vol.98 (4), p.533-537

2013

Volltextzugriff (PDF)

PPM1A and PPM1B act as IKKβ phosphatases to terminate TNFα-induced IKKβ-NF-κB activation

Cellular signalling, 2009-01, Vol.21 (1), p.95-102

2009

Volltextzugriff (PDF)

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies

Journal of immunotherapy (1997), 2013-01, Vol.36 (1), p.66-76

2013

Volltextzugriff (PDF)

Quantitative EBV Viral Loads and Immunosuppression Alterations can Decrease PTLD Incidence in Pediatric Liver Transplant Recipients

American journal of transplantation, 2005-09, Vol.5 (9), p.2222-2228

2005

Volltextzugriff (PDF)

Changes in chemokine receptor expression of regulatory T cells after ex vivo culture

Journal of immunotherapy (1997), 2012-05, Vol.35 (4), p.329-336

2012

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(89)

Sprache

Englisch
(89)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Humans
(39)
Hematology
(20)
Biological And Medical Sciences
(19)
Hematology, Oncology And Palliative Medicine
(19)
Medical Sciences
(18)
Female
(17)
Immunotherapy
(15)
Male
(13)
Oncology
(13)
Lymphocytes T
(11)
T-Lymphocytes, Cytotoxic - Immunology
(11)
Antigens
(10)
Immunology
(10)
Lymphocytes
(10)
T-Lymphocytes - Immunology
(10)
Transplantation
(10)
Adult
(8)
Tumors
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Biology Of Blood And Marrow Transplantation
(18)
Blood
(15)
Cytotherapy
(10)
Leukemia
(5)
Cancer Research
(4)
Haematologica
(3)
Journal Of Clinical Oncology
(3)
Molecular Therapy
(3)
American Journal Of Transplantation
(2)
Journal Of Immunotherapy
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma leukemia effects and safety

Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant

Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals

CD30‐CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR THERAPY OF HODGKIN LYMPHOMA (HL)

Direct comparison of in vivo fate of second and third-generation CD19-specific chimeric antigen receptor (CAR)-T cells in patients with b cell non-hodgkin lymphoma (B-NHL): Reversal of toxicity from tonic signaling

Late donor cardiectomy after paediatric heterotopic cardiac transplantation

Chimeric Antigen Receptor Gene-Modified Virus-Specific T-Cell Expanded in Patients with Reactivated Epstein-Barr Virus Post Allogeneic Stem Cell Transplant

Generation and administration of autologous T cells transduced with a 3rd generation GD2 chimeric antigen receptor for patients with relapsed or refractory neuroblastoma

Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L IL-2 tumor vaccine

Generation of EBV-Specific CD4+ Cytotoxic T Cells from Virus Naive Individuals

Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?"

Ultra low-dose IL-2 mediated expansion of regulatory T cells as GvHD prophylaxis for recipients of allogeneic hematopoietic stem cells

Naïve T-cell-derived CTL recognize atypical epitopes of CMVpp65 with higher avidity than CMV-seropositive donor-derived CTL - a basis for treatment of post-transplant viral infection by adoptive transfer of T-Cells from virus-naïve donors

Improving immune reconstitution after cord blood transplantation using ex vivo expanded virus-specific T cells: a phase I clinical study

Infusion of CD19-directed/multivirus specific-cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation for B cell malignancies

Immunotherapy: B7H3-CAR NK CELLS AND DNR CO-TRANSDUCED NK SHOWS MAINTAIN THEIR POTENCY AGAINST TGF-B MEDIATED IMMUNE SUPPRESSION

Genetic modification of human T lymphocytes for the treatment of hematologic malignancies

Human antibody titers to Epstein–Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay

Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease

PPM1A and PPM1B act as IKKβ phosphatases to terminate TNFα-induced IKKβ-NF-κB activation

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies

Quantitative EBV Viral Loads and Immunosuppression Alterations can Decrease PTLD Incidence in Pediatric Liver Transplant Recipients

Changes in chemokine receptor expression of regulatory T cells after ex vivo culture

Suchergebnisse filtern